AKT1 and colorectal cancer: For example, increasing studies have found that PI3K/Akt-related inflammatory pathways are dysregulated in colorectal cancer cells [7], therefore, anti-inflammatory, cytotoxic, pro-apoptotic, and cycle-regulating drugs are often applied to treat colorectal tumors [8,9].